Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Ethionamide-induced pellagroid dermatitis resembling lichen simplex chronicus: A report of two cases

Gaurav Garg, Uday Khopkar
 Department of Skin and VD, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India

Correspondence Address:
Uday Khopkar
Department of Dermatology, Seth GS Medical College and KEM Hospital, Parel, Mumbai - 400 012, Maharashtra
India
How to cite this article:
Garg G, Khopkar U. Ethionamide-induced pellagroid dermatitis resembling lichen simplex chronicus: A report of two cases. Indian J Dermatol Venereol Leprol 2011;77:534
Copyright: (C)2011 Indian Journal of Dermatology, Venereology, and Leprology

Abstract

Pellagra is a niacin deficiency disorder characterized clinically by diarrhea, dermatitis, and dementia. However, few drugs also cause pellagroid dermatitis. Recently, we encountered two cases of pellagroid dermatitis; both were on second line of antituberculosis drugs. Case 1 was of multidrug-resistant pulmonary tuberculosis. Patient was on ethionamide since one year before developing pellagroid dermatitis. Case 2 was of central nervous system tuberculoma and was on second line of antitubercular drugs. This patient was on ethionamide and isoniazid (INH) since six months before developing pellagroid dermatitis. This patient had previously taken first line of antituberculous therapy, inclusive of INH, for 1 year without any dermatitis. The skin lesions in both patients were symmetric hyperpigmented thickened plaques with prominent skin markings resembling lichen simplex chronicus. Nicotinamide 300 mg in three divided doses healed the lesions completely within 4 weeks and 3 weeks in first and second patient, respectively.
Keywords: Antitubercular drugs, ethionamide, niacin, pellagroid dermatitis

Introduction

The traditionally remembered classical triad of symptoms of pellagra, i.e., 3 d′s; dermatitis, diarrhea, and dementia, is very occasionally seen in today′s era. Most cases are less typical and borderline in nature. [1],[2],[3] Pellagra is caused by deficiency of niacin or its precursor tryptophan. It mainly occurs in undernourished patients with history of alcohol abuse. [1] Uncommonly, it occurs secondary to drugs, especially anitubercular drugs such as isoniazid (mainly) and ethionamide (rarely) and phenytoin, chloramphenicol, azathioprine, 5-fluorouracil, and phenobarbital. [2],[3] It is characterized both by dermatologic and systemic manifestations.

Case Reports

Case 1

A 32-year-old house wife presented with well-defined, hyperpigmented, hyperkeratotic, symmetrical, thick scaly plaques surrounded by erythema over dorsal aspect of both hands and first three toes of both feet since 15 to 20 days [Figure - 1]. Lesions were increasing gradually in size. She also complained of mild to moderate burning and itching over lesions while going out in sun. Mild erythema of lips and tongue were present in the patient. No history of diarrhea or affection of mental faculties was present. There was no lesion on "V" area of neck. One and half years back, she was diagnosed as pulmonary tuberculosis and was started on four drug regimen of isoniazid, rifampicin, ethambutol, and pyrazinamide. After four months of treatment with the above four drugs, she developed cold abscess in the sternal region, which was drained and the pus culture was suggestive of multidrug-resistant tuberculosis, resistant to all four drugs of first-line antituberculous regimen. She was started on second-line antitubercular regimen consisting of ethionamide 250 mg bid, PAS granules one measure (3.5 gm) bid, and ofloxacin 400 mg bid, 1 year back. Injection kanamycin 500 mg intramuscular alternate day and clofazimine 100 mg od were also taken for initial six months of second-line antitubercular regimen. She denied any exposure to chemical agents and contact allergens. A differential diagnosis of pellagroid dermatitis, zinc deficiency, acanthosis nigricans, marginal keratoderma, and lichen simplex chronicus was kept.

Figure 1: Pre- and post-treatment photographs of patient one. Hyperpigmented, hyperkeratotic, well-defined plaques surrounded with dusky erythema were present over dorsum of both hands mimicking lichen simplex chronicus. Lesions cleared completely after four weeks of nicotinamide therapy

Her blood investigations were: Complete blood count - 11 000/mm 3 , erythrocyte sedimentation rate - 36.0 mm at the end of one hour, blood urea nitrogen - 7.0 mg/dl, and serum electrolyte levels - Na + 136.0 mEq/l, K + 4.2 mEq/l, Cl - 101.0 mEq/l which were within normal limits. Serum zinc levels were 88.9 μg/dl and total proteins were 7.6 mg/dl (albumin, 3.6 mg/dl) which were also within normal limits. Skin biopsy on scanner view showed hyperplastic epidermis with moderate thickening of the granular and corneal layer. Sparse superficial perivascular lymphocytic and neutrophilic infiltrate was present [Figure - 2]. On higher magnification, ballooning of upper spinous and granular layer with eosinophil staining of lower stratum corneum with focal parakeratosis was present [Figure - 2].

Figure 2: Biopsy sample from margin of hyperpigmented, hyperkeratotic plaque of patient one. Scanner view shows hyperplastic epidermis with moderate thickening of the granular and corneal layer with sparse superficial perivascular lymphocytic and neutrophilic infiltrate (H and E, ×40). Higher magnification shows ballooning of upper spinous and granular layer with eosinophil staining of lower stratum corneum. Focal parakeratosis is present (H and E, ×400)

Based on history, physical examination, and investigations, a diagnosis of drug-induced pellagra-like dermatitis was established. Patient was started on nicotinamide (300 mg/day) in three dividing doses with multivitamin B complex while continuing her multidrug-resistant antitubercular regimen. Her lesions healed completely within 4 weeks of nicotinamide therapy [Figure - 1]. Proper nutrition with high protein diet and sun screen creams was also added to her treatment protocol. She was advised to continue nicotinamide supplements 100 mg/day till the completion of the course of antitubercular therapy.

Case 2

A 21-year-old female presented with multiple, symmetric, hyperpigmented, hyperkeratotic, well-defined plaques surrounded by dusky discoloration over dorsum of both hands, more on middle and terminal phalanges of fingers, gradually progressive in size and thickness since three months. Similar lesions were also present over medial and lateral aspect of both feet [Figure - 3]. No history of itching and burning was present over lesions while going out in sun. No history of diarrhea and mental confusion was present. There was no cheilitis or glossitis. Also, no lesion was present over "V" area of neck. Five years back, patient was diagnosed as pulmonary tuberculosis and was started on four drug regimen of isoniazid, rifampicin, ethambutol, and pyrazinamide. After three months of regular treatment, patient discontinued the treatment on its own. Three years back, she was diagnosed as tubercular meningitis and started on first-line antitubercular drugs for one year. She successfully completed her course. No side effect was noted during this period. After one year of completion of course of antitubercular drugs, the patient again got convulsions and her brain MRI was suggestive of multiple tuberculomas. Patient was started on second line of antitubercular drugs nine months back, including ethionamide 250 mg bid, isoniazid 300 mg od, rifampicin 600 mg od, levofloxacin 750 mg od, injection kanamycin 0.5 ml intramuscular weekly, carbamazepine 200 mg bid, and clobazam 50 mg od. After 6 months of second-line antitubercular therapy, she started developing hyperpigmented, hyperkeratotic, and mildly scaly plaques over dorsum of both hands and medial and lateral aspect of both feet. She denied any exposure to chemical agents and contact allergens. A differential diagnosis of pellagroid dermatitis, acanthosis nigricans, psoriasis, lichen simplex chronicus, marginal keratoderma, and zinc deficiency was kept.

Figure 3: Pre- and post-treatment photographs of patient two showing symmetric, hyperpigmented, hyperkeratotic, well-defined plaques surrounded by dusky discoloration over medial and lateral aspect of both hands and feet. Lesions healed completely after three weeks of nicotinamide therapy

Her blood investigations were: Complete blood count - 6 000/ml, erythrocyte sedimentation rate - 23.0 mm at the end of one hour, blood urea nitrogen - 6.0 mg%, serum creatinine - 0.6 mg%, total protein - 6.6 mg% (albumin, 3.0 mg%), SGOT - 69 U/l, SGPT - 30 U/l, and serum electrolyte levels - Na + 137.0 mEq/l, K + 3.3 mEq/l, Cl - 101 mEq/l. Serum zinc levels - 86.4 μg/dl and serum B 12 levels - 1048 pg/ml were within normal limits. Her skin biopsy from the periphery of the hyperpigmented plaque showed hyperkeratosis, focal parakeratosis, acanthosis, and sparse superficial perivascular lymphocytic and neutrophilic infiltrate.

Based on history, physical examination, and investigations, a diagnosis of drug-induced pellagra-like dermatitis was established. She was started on nicotinamide (300 mg/day) in three divided doses with multivitamin B complex. Proper nutrition with high protein diet and sun screen creams was also advised. Her lesions healed completely within three weeks of nicotinamide therapy [Figure - 3]. She was advised to continue nicotinamide supplements 100 mg/day until the course of her antitubercular medicines complete.

Discussion

Pellagra is a systemic disease resulting from deficiency of niacin or vitamin B 3 . The dietary tryptophan produces niacin in the presence of vitamins B 2 and B 6 . [2] Niacin is an essential component of coenzyme 1 (oxidized form of nicotinamide adenine dinucleotide [NAD]) and coenzyme 2 (oxidized form of nicotinamide adenine dinucleotide phosphate [NADP]) which are required for adequate cellular functioning and various metabolic reactions in our body. [1],[2] Historically, pellagra is a disease of a maize-eating population. It has also been reported in India in some jowar (Sorghum vulgare)-eating populations. [4] Amino-acid imbalance caused by an excess of leucine is the cause of pellagra in both jowar and maize eaters. Excess of leucine appears to interfere in the conversion of tryptophan to niacin. [4]

Malabsorption syndromes (jejunoileitis, gastroenterostomy, subtotal gastrectomy, Crohn′s disease), chronic alcoholism, [1] metabolic derangements (Hartnup disease, [5],[6] carcinoid syndrome [7],[8] ), and drugs [2] (INH, 6-mercaptopurine, 5-fluorouracil, pyrazinamide, phenytoin, chloramphenicol, azathioprine, phenobarbitone, ethionamide) are the causes of pellagra. In chronic alcoholics, pellagra occurs as a result of nutritionally poor diet and malabsorption. The hepatic cell also inefficiently utilizes nicotinic acid in chronic alcoholics. [1] In Hartnup disease, due to the defect in the neutral brush border system, malabsorption of amino acids as tryptophan occurs. [5],[6] However, in carcinoid syndrome, there is increased conversion of tryptophan to serotonin, leading to decreased production of niacin. [7],[8]

Antitubercular drugs, isoniazid, pyrazinamide, and ethionamide, are structurally similar with NAD. [9] All these substances have a ring of five carbon atoms and one of nitrogen in position 4. [9] These antitubercular drugs competitively replace NAD from the metabolic pathways. Hence, tissues with high energy requirements, like brain, or with high turnover rate like skin and gut, get affected in pellagra. [10] Moreover, these drugs are also hepatotoxic and this further adds to the decreased utilization of absorbed niacin and tryptophan. [2]

Inhibition of conversion of tryptophan to niacin by 5-fluorouracil leads to pellagra, and 6-mercaptopurine causes pellagra-like dermatitis by inhibiting Korenberg′s enzyme (NAD phosphorylase). [2],[10] Other drugs like phenytoin, chloramphenicol, azathioprine, and phenobarbital interfere in the tryptophan-niacin pathway and lead to pellagroid dermatitis [Table - 1]. The exquisite photosensitivity seen in pellagra may result from a deficiency of urocanic acid and/or cutaneous accumulation of kynurenic acid that may induce a phototoxic reaction. [6],[10]

Table 1: List of drugs causing pellagroid dermatitis with their probable mechanism of action

Both of our patients did not have any lesion over V area of neck. Also, in contrast to classical pellagra, diarrhea was not a complaint in both of the patients. No affection of mental faculties was present in both the patients. Both the patients had hyperpigmented, hyperkeratotic plaques over dorsum of both hands and feet only. Cheilitis and glossitis were present only in the first patient.

Both of our patients were on antitubercular drugs. First patient was on ethionamide, while second patient was on ethionamide and isoniazid. Second patient had earlier taken isoniazid for one year without any adverse effects. In second patient, the symptoms of pellagroid dermatitis developed only after introduction of ethionamide. Ethionamide is more toxic than isoniazid and because of more toxicity, ethionamide is placed in second line of antitubercular drugs. [9] In second patient, probably the ethionamide had exacerbated the symptoms of pellagroid dermatitis.

Both of our patients responded well to nicotinamide supplementation, which confirms our diagnoses.

Unfortunately, pellagra is a diagnosis based on clinical picture because measurement of nicotinic acid level is a time-consuming and expensive procedure. However, treatment with nicotinic acid rapidly resolves diarrhea and confusion, with a gradual improvement in skin.

Isoniazid is the first-line drug for antitubercular therapy. When this drug was introduced, a lot of cases of pellagroid dermatitis came to light. Despite being coadministered with pyridoxine, there are case reports of development of pellagroid dermatitis in patients on isoniazid therapy. [11] Ethionamide is used only as a second-line drug for the management of tuberculosis. With the increase in multidrug-resistant tuberculosis patients especially on the backdrop of HIV infection, ethionamide-induced pellagroid dermatitis may be observed more frequently in the near future.

Nicotinamide is preferred over niacin in the treatment of pellagroid dermatitis because it does not cause vasomotor disturbances (flushing, itching, or burning). Nicotinamide is administered orally 100 to 300 mg/day in three divided doses [12] with vitamin B complex supplementation and high protein diet. A dose of 100 mg three times a day can be given by intramuscular route. In patients of encephalopathy, 1000 mg of nicotinamide is recommended orally in addition to 100 to 200 mg parenterally. Neurological symptoms disappear within 24 to 48 hours, but skin lesions may take 3 to 4 weeks to resolve. [13] Maintenance dose with nicotinamide 50 to 100 mg/day is recommended.

These cases highlight lichen simplex chronicus-like presentation of ethionamide-induced pellagroid dermatitis.

References
1.
Stratigos JD, Katsambas A. Pellagra: A still existing disease. Br J Dermatol 1977;96:99-106.
[Google Scholar]
2.
Karthikeyan K, Thappa DM. Pellagra and Skin. Int J Dermatol 2002;41:476-81.
[Google Scholar]
3.
Hegyi J, Schwartz RA, Hegyi V. Pellagra: Dermatitis, dementia, and diarrhea. Int J Dermatol 2004;43:1-5.
[Google Scholar]
4.
Park K. Nutrition and health. In: Park K, editor. Park's Textbook of Preventive and Social Medicine. 20 th ed. Jabalpur, India: M/S Banarsidas Bhanot Publishers; 2009. p. 526-80.
th ed. Jabalpur, India: M/S Banarsidas Bhanot Publishers; 2009. p. 526-80.'>[Google Scholar]
5.
Milne MD, Crawford MA, Girao CB, Loughridge LW. The metabolic disorder in Hartnup disease. Q J Med 1959;28:407-21.
[Google Scholar]
6.
Dogliotti M, Liebowitz M, Downing DT, Strauss JS. Nutritional influences of pellagra on sebum composition. Br J Dermatol 1977;97:25-8.
[Google Scholar]
7.
Castiello RJ, Lynch PJ. Pellagra and carcinoid syndrome. Arch Dermatol 1972;105:574-7.
[Google Scholar]
8.
Sjoerdsma A, Weissbach H, Udenfriend S. A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Am J Med 1956;20:520-32.
[Google Scholar]
9.
Sweetman SC. Nutritional agents and vitamins. In: Sweetman SC, editor. Martindale the complete drug reference. 36 th ed. London: RPS Publishing; 2009. p. 1957-9.
[Google Scholar]
10.
Hendricks WM. Pellagra and pellagra like dermatoses. Etiology, differential diagnosis, dermatopathology and treatment. Semin Dermatol 1991;10:282-92.
[Google Scholar]
11.
Darvay A, Basarab T, McGregor JM, Russell-Jones R. Isoniazid induced pellagra despite pyridoxine supplementation. Clin Exp Dermatol 1999;24:167-9.
[Google Scholar]
12.
Soni BP, McLaren DS, Sherertz MF. Cutaneous changes in nutritional disease. In: Freedberg IM, Eisen AZ, Wolf K, Austen KF, Goldsmith LA, Katz SL, editors. Dermatology in General Medicine. 5 th ed. New York: McGraw-Hill; 1999. p. 1725-37.
[Google Scholar]
13.
Gopalan C, Jaya Rao KS. Nutritional deficiencies in man: Niacin. In: Recheigl J, editor. Section E. Nutritional disorders. West Palm beach, FL: CRC press; 1978. p. 23-31.
[Google Scholar]

Fulltext Views
4,724

PDF downloads
2,260
Show Sections